The global thrombus precursor protein market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Thrombus precursor protein (TpP) is a biomarker that indicates the vulnerability of people to serious CVD that is associated with the occlusion of coronary blood vessels. Additionally, it is also one of the components of coagulation and fibrinolytic pathways. The major factor driving the demand for the thrombus precursor protein market is the increasing prevalence of cardiac conditions across the globe.

According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of mortality globally with a mortality rate of an estimated 17.9 million people in 2019 which represented 32% of all global mortalities. Additionally, out of these, 85% were due to heart attack and stroke. Furthermore, in the same year, 17 million premature mortalities were under the age of 70 due to non-communicable diseases. Moreover, TpP assay identifies active thrombosis in several clinical conditions which include early myocardial infarction (MI). Furthermore, monitoring of TpP levels plays an important role for people with CVD. 

Apart from this, North America is anticipated to hold a prominent share in the market. This is due to the presence of key players in the market and the high presence of CVDs such as heart diseases in the region. However, the growth of the market is hampered due to the lack of awareness about TpP. Some major players in the market include Hoffman La Roche Ltd., Abbott Laboratories, Randox Laboratories, among others. 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Type
• By Application

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- F. Hoffman La Roche Ltd., and Randox Laboratories, among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Thrombus Precursor Protein Market Report by Segment

By Type 

• Mouse Thrombus Precursor Protein
• Sheep Thrombus Precursor Protein
• Human Thrombus Precursor Protein
• Chicken Thrombus Precursor Protein
• Others

By Application

• Hospital
• Clinics 
• Others

Global Thrombus Precursor Protein Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa